Other

Debt issuances

Amgen Debt issuances decreased by 83.3% to $4.00B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ2 2017
Last reportedQ1 2026Apr 30, 2026

How to read this metric

High issuance may indicate aggressive growth strategies or acquisitions, but also increases the company's leverage and interest burden.

Detailed definition

This represents the total face value of new debt instruments issued by the company during the reporting period. It refle...

Peer comparison

Commonly reported by capital-intensive firms and conglomerates.

Metric ID: other_debt_instrument_face_amount

Historical Data

4 periods
 Q1 '23Q2 '23Q3 '23Q1 '26
Value$24.00B$24.00B$24.00B$4.00B
QoQ Change—+0.0%+0.0%-83.3%
Range$4.00B – $24.00B

Debt issuances at Other Companies

Berkshire Hathaway logo
Berkshire HathawayBRK.AView metric
LTR
LTRLTRView metric
Berkshire Hathaway logo
Berkshire HathawayBRK.AView metric
Ameren logo
AmerenAEEView metric
Arch Capital Group logo
Arch Capital GroupACGLView metric
Bank of America logo
Bank of AmericaBACView metric

Frequently Asked Questions

What is Amgen's debt issuances?
Amgen (AMGN) reported debt issuances of $4.00B in Q1 2026.
What does debt issuances mean?
The total value of new debt the company has taken on during the period.